Claire Loiseau
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Claire Loiseau has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
- Denise L. Doolan
Centre for Molecular Therapeutics, Australian Institute of Tropical Health and Medicine, James Cook University, Cairns, QLD, Australia
5 shared publications - Pierre Delobel
Affiliations INSERM UMR 1291, CNRS UMR 5051, Université de Toulouse, Toulouse Institute for Infectious and Inflammatory Diseases, Toulouse, France, CHU de Toulouse, Service des Maladies Infectieuses et Tropicales, Toulouse, France, Université de Toulouse, Toulouse, France
4 shared publications - Jacques Izopet
Laboratoire de Virologie, Institut Fédératif de Biologie, CHU de Toulouse, Hôpital Purpan, 31059 Toulouse, France
3 shared publications - Martha M. Cooper
Australian Institute of Tropical Health and Medicine, James Cook University, Cairns, QLD 4878, Australia
3 shared publications Adrien Saliou
Laboratoire de Virologie, Hôpital Purpan, Toulouse, F-31300 France
2 shared publicationsBoubacar Traore
Mali International Center of Excellence in Research University of Sciences, Technique and Technology of Bamako Bamako Mali
2 shared publications
Latest Publications
- 2 April 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Régulation du trafic des lymphocytes T CD4+ vers la muqueuse intestinale au cours de la reconstitution immunitaire sous traitement antirétroviral
Lors de l'infection par le VIH-1, l'intégrité de la barrière immunitaire muqueuse est altérée du fait d'une profonde déplétion des lymphocytes T CD4+ intestinaux, notamment des lymphocytes Th17, une sous population de lymphocytes exerçant un rôle majeur dans la lutte contre les bactéries et certains champignons. La translocation de produits microbiens de la lumière intestinale dans la circulation sanguine systémique, liée à la perte des lymphocytes Th17, est une source d'inflammation généralisée délétère. Malgré la mise en place d'un traitement antirétroviral, chez la plupart des patients, la reconstitution des lymphocytes T CD4+ de la lamina propria est différée et incomplète par rapport à celle du sang périphérique. Les travaux exposés dans ce manuscrit suggèrent que chez les patients VIH-1+ traités, une diminution de la production de la chimiokine CCL20 altère l'axe de chimiotactisme CCR6-CCL20, particulièrement important pour les lymphocytes Th17, affaiblissant ainsi l'adressage de ces cellules à la muqueuse intestinale. Les résultats obtenus ne sont pas en faveur d'un rôle direct du virus dans la diminution observée de CCL20. L'infection par différentes souches virales d'un système d'histocultures de tissu intestinal développé au laboratoire induit, au contraire, une augmentation de la production de la chimiokine CCL20. La stimulation de cultures de cellules épithéliales intestinales primaires, spécialement mises au point lors de ce projet, par différentes protéines virales ne montrent pas non plus d'effet négatif sur la production de la chimiokine CCL20. La stimulation des cellules épithéliales intestinales primaires par différents ligands des récepteurs de l'immunité innée aux pathogènes (PRR) a également permis d'écarter la potentielle responsabilité de la translocation résiduelle de produits microbiens observée chez les patients VIH-1+ dans la diminution de la production de CCL20. L'analyse de la distribution des différentes populations lymphocytaires dans les compartiments sanguin et intestinal des patients VIH-1+ traités a mis en évidence une augmentation d'une population de lymphocytes T régulateurs dans l'intestin grêle, qui n'expriment pas le récepteur CCR6 (Treg CCR6-). L'étude présentée souligne la persistance d'un déséquilibre du ratio lymphocytes Th17/Treg CCR6- malgré un traitement antirétroviral. La perturbation de l'environnement cytokinique, conséquence de la modification du ratio lymphocytes Th17/Treg CCR6- semble impliquée dans la diminution de la chimiokine CCL20 observée chez les patients VIH-1+ traités. La stimulation des cellules épithéliales intestinales primaires par l'IL-17A, synthétisée par les lymphocytes Th17, augmente la production de CCL20, alors que la stimulation par l'IL-10 et le TGF-ß1, produites par les lymphocytes Treg, diminue cette production. La co-culture de cellules épithéliales primaires avec différents ratio de lymphocytes T triés et stimulés, reproduisant ex vivo l'interaction entre l'épithélium intestinal et la lamina propria sous jacente, confirme l'influence du ratio lymphocytes Th17/Treg CCR6- sur la production de CCL20 par les cellules épithéliales intestinales. Ces travaux démontrent que l'axe de chimiotactisme CCR6-CCL20 est altéré chez les patients VIH-1+ malgré le traitement antirétroviral prolongé et que la persistance d'un déséquilibre du ratio lymphocytes Th17/Treg CCR6- dans la lamina proria pourrait contribuer à la diminution de la production de CCL20 par les entérocytes, soulignant l'existence d'un cercle vicieux entre la diminution de l'expression de CCL20 et le défaut d'adressage des lymphocytes Th17 à la muqueuse intestinale.
- 2 April 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Régulation du trafic des lymphocytes T CD4+ vers la muqueuse intestinale au cours de la reconstitution immunitaire sous traitement antirétroviral
Lors de l'infection par le VIH-1, l'intégrité de la barrière immunitaire muqueuse est altérée du fait d'une profonde déplétion des lymphocytes T CD4+ intestinaux, notamment des lymphocytes Th17, une sous population de lymphocytes exerçant un rôle majeur dans la lutte contre les bactéries et certains champignons. La translocation de produits microbiens de la lumière intestinale dans la circulation sanguine systémique, liée à la perte des lymphocytes Th17, est une source d'inflammation généralisée délétère. Malgré la mise en place d'un traitement antirétroviral, chez la plupart des patients, la reconstitution des lymphocytes T CD4+ de la lamina propria est différée et incomplète par rapport à celle du sang périphérique. Les travaux exposés dans ce manuscrit suggèrent que chez les patients VIH-1+ traités, une diminution de la production de la chimiokine CCL20 altère l'axe de chimiotactisme CCR6-CCL20, particulièrement important pour les lymphocytes Th17, affaiblissant ainsi l'adressage de ces cellules à la muqueuse intestinale. Les résultats obtenus ne sont pas en faveur d'un rôle direct du virus dans la diminution observée de CCL20. L'infection par différentes souches virales d'un système d'histocultures de tissu intestinal développé au laboratoire induit, au contraire, une augmentation de la production de la chimiokine CCL20. La stimulation de cultures de cellules épithéliales intestinales primaires, spécialement mises au point lors de ce projet, par différentes protéines virales ne montrent pas non plus d'effet négatif sur la production de la chimiokine CCL20. La stimulation des cellules épithéliales intestinales primaires par différents ligands des récepteurs de l'immunité innée aux pathogènes (PRR) a également permis d'écarter la potentielle responsabilité de la translocation résiduelle de produits microbiens observée chez les patients VIH-1+ dans la diminution de la production de CCL20. L'analyse de la distribution des différentes populations lymphocytaires dans les compartiments sanguin et intestinal des patients VIH-1+ traités a mis en évidence une augmentation d'une population de lymphocytes T régulateurs dans l'intestin grêle, qui n'expriment pas le récepteur CCR6 (Treg CCR6-). L'étude présentée souligne la persistance d'un déséquilibre du ratio lymphocytes Th17/Treg CCR6- malgré un traitement antirétroviral. La perturbation de l'environnement cytokinique, conséquence de la modification du ratio lymphocytes Th17/Treg CCR6- semble impliquée dans la diminution de la chimiokine CCL20 observée chez les patients VIH-1+ traités. La stimulation des cellules épithéliales intestinales primaires par l'IL-17A, synthétisée par les lymphocytes Th17, augmente la production de CCL20, alors que la stimulation par l'IL-10 et le TGF-ß1, produites par les lymphocytes Treg, diminue cette production. La co-culture de cellules épithéliales primaires avec différents ratio de lymphocytes T triés et stimulés, reproduisant ex vivo l'interaction entre l'épithélium intestinal et la lamina propria sous jacente, confirme l'influence du ratio lymphocytes Th17/Treg CCR6- sur la production de CCL20 par les cellules épithéliales intestinales. Ces travaux démontrent que l'axe de chimiotactisme CCR6-CCL20 est altéré chez les patients VIH-1+ malgré le traitement antirétroviral prolongé et que la persistance d'un déséquilibre du ratio lymphocytes Th17/Treg CCR6- dans la lamina proria pourrait contribuer à la diminution de la production de CCL20 par les entérocytes, soulignant l'existence d'un cercle vicieux entre la diminution de l'expression de CCL20 et le défaut d'adressage des lymphocytes Th17 à la muqueuse intestinale.
- 15 December 2021
- Published by American Society for Microbiology in Clinical Microbiology Reviews
- Vol. 34 (4) , e0034820
Natural-Product-Based Solutions for Tropical Infectious Diseases
About half of the world’s population and 80% of the world’s biodiversity can be found in the tropics. Many diseases are specific to the tropics, with at least 41 diseases caused by endemic bacteria, viruses, parasites, and fungi. Such diseases are of increasing concern, as the geographic range of tropical diseases is expanding due to climate change, urbanization, change in agricultural practices, deforestation, and loss of biodiversity.
- 15 December 2021
- Published by American Society for Microbiology in Clinical Microbiology Reviews
- Vol. 34 (4) , e0034820
Natural-Product-Based Solutions for Tropical Infectious Diseases
About half of the world’s population and 80% of the world’s biodiversity can be found in the tropics. Many diseases are specific to the tropics, with at least 41 diseases caused by endemic bacteria, viruses, parasites, and fungi. Such diseases are of increasing concern, as the geographic range of tropical diseases is expanding due to climate change, urbanization, change in agricultural practices, deforestation, and loss of biodiversity.
- Open Access
- 1 January 2021
- Published by Wiley in Clinical & Translational Immunology
- Vol. 10 (3) , e1265
Memory CD8+ T cell compartment associated with delayed onset of Plasmodium falciparum infection and better parasite control in sickle‐cell trait children
Objectives: Study of individuals with protection from Plasmodium falciparum (Pf) infection and clinical malaria, including individuals affected by the sickle‐cell trait (HbAS), offers the potential to identify cellular targets that could be translated for therapeutic development. We previously reported the first involvement of cellular immunity in HbAS‐associated relative protection and identified a novel subset of memory‐activated NK cells that was enriched in HbAS children and associated with parasite control. We hypothesised that other memory cell subsets might distinguish the baseline profile of HbAS children and children with normal haemoglobin (HbAA).Methods: Subsets of memory T cells and NK cells were analysed by flow cytometry in paired samples collected from HbAS and HbAA children, at baseline and during the first malaria episode of the ensuing transmission season. Correlations between cell frequencies and features of HbAS‐mediated protection from malaria were determined.Results: HbAS children displayed significantly higher frequency of memory CD8+ T cells at baseline than HbAA children. Baseline frequency of memory CD8+ T cells correlated with features of HbAS‐mediated protection from malaria. Exploration of memory CD8+ T cell subsets revealed that central memory CD8+ T cell frequency was higher in HbAS children than in HbAA children.Conclusion: This study shows that HbAS children develop a larger memory CD8+ T cell compartment than HbAA children, and associates this compartment with better control of subsequent onset of infection and parasite density. Our data suggest that central memory CD8+ T cells may play an important role in the relative protection against malaria experienced by HbAS individuals, and further work to investigate this is warranted.
- 1 January 2021
- Published by Wiley in Clinical & Translational Immunology
- Vol. 10 (3) , e1265
Open AccessMemory CD8+ T cell compartment associated with delayed onset of Plasmodium falciparum infection and better parasite control in sickle‐cell trait children
Objectives: Study of individuals with protection from Plasmodium falciparum (Pf) infection and clinical malaria, including individuals affected by the sickle‐cell trait (HbAS), offers the potential to identify cellular targets that could be translated for therapeutic development. We previously reported the first involvement of cellular immunity in HbAS‐associated relative protection and identified a novel subset of memory‐activated NK cells that was enriched in HbAS children and associated with parasite control. We hypothesised that other memory cell subsets might distinguish the baseline profile of HbAS children and children with normal haemoglobin (HbAA).Methods: Subsets of memory T cells and NK cells were analysed by flow cytometry in paired samples collected from HbAS and HbAA children, at baseline and during the first malaria episode of the ensuing transmission season. Correlations between cell frequencies and features of HbAS‐mediated protection from malaria were determined.Results: HbAS children displayed significantly higher frequency of memory CD8+ T cells at baseline than HbAA children. Baseline frequency of memory CD8+ T cells correlated with features of HbAS‐mediated protection from malaria. Exploration of memory CD8+ T cell subsets revealed that central memory CD8+ T cell frequency was higher in HbAS children than in HbAA children.Conclusion: This study shows that HbAS children develop a larger memory CD8+ T cell compartment than HbAA children, and associates this compartment with better control of subsequent onset of infection and parasite density. Our data suggest that central memory CD8+ T cells may play an important role in the relative protection against malaria experienced by HbAS individuals, and further work to investigate this is warranted.
- Open Access
- 20 March 2020
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 11, 402
An Analytically and Diagnostically Sensitive RNA Extraction and RT-qPCR Protocol for Peripheral Blood Mononuclear Cells
Reliable extraction and sensitive detection of RNA from human peripheral blood mononuclear cells (PBMCs) is critical for a broad spectrum of immunology research and clinical diagnostics. RNA analysis platforms are dependent upon high quality and high quantity mRNA, but this can be challenging with human samples and limited PBMC numbers. We provide herein a critical evaluation of the current generation of RNA-based kits for PBMCs and present a reverse transcription quantitative PCR (RTqPCR) assay optimized for both analytically and diagnostically sensitive cell-based RNA-based applications. Specifically, four RNA extraction kits, four SYBR master-mix kits, and four reverse transcription kits were tested. RNA extraction and RTqPCR reaction efficiency were evaluated with commonly used reference and cytokine genes. Significant variation in RNA expression of reference genes was apparent, and absolute quantification based on cell number was established as an effective RTqPCR normalization strategy. We defined an optimized RNA extraction and RTqPCR protocol with an analytical sensitivity capable of single cell RNA detection. The diagnostic sensitivity of this assay was sufficient to show a CD8+ T cell epitope hierarchy with as few as 1x104 cells. Finally, we compared our optimized RNA extraction and RTqPCR protocol with current best-practice immune assays and demonstrated that our assay is a sensitive alternative to protein-based assays, especially with limited PBMCs number. This protocol with high analytical and diagnostic sensitivity has broad applicability for both primary research and clinical practice.
- 20 March 2020
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 11, 402
Open AccessAn Analytically and Diagnostically Sensitive RNA Extraction and RT-qPCR Protocol for Peripheral Blood Mononuclear Cells
Reliable extraction and sensitive detection of RNA from human peripheral blood mononuclear cells (PBMCs) is critical for a broad spectrum of immunology research and clinical diagnostics. RNA analysis platforms are dependent upon high quality and high quantity mRNA, but this can be challenging with human samples and limited PBMC numbers. We provide herein a critical evaluation of the current generation of RNA-based kits for PBMCs and present a reverse transcription quantitative PCR (RTqPCR) assay optimized for both analytically and diagnostically sensitive cell-based RNA-based applications. Specifically, four RNA extraction kits, four SYBR master-mix kits, and four reverse transcription kits were tested. RNA extraction and RTqPCR reaction efficiency were evaluated with commonly used reference and cytokine genes. Significant variation in RNA expression of reference genes was apparent, and absolute quantification based on cell number was established as an effective RTqPCR normalization strategy. We defined an optimized RNA extraction and RTqPCR protocol with an analytical sensitivity capable of single cell RNA detection. The diagnostic sensitivity of this assay was sufficient to show a CD8+ T cell epitope hierarchy with as few as 1x104 cells. Finally, we compared our optimized RNA extraction and RTqPCR protocol with current best-practice immune assays and demonstrated that our assay is a sensitive alternative to protein-based assays, especially with limited PBMCs number. This protocol with high analytical and diagnostic sensitivity has broad applicability for both primary research and clinical practice.
- Open Access
- 1 January 2020
- Published by Wiley in Clinical & Translational Immunology
- Vol. 9 (4) , e1125
A novel population of memory‐activated natural killer cells associated with low parasitaemia in Plasmodium falciparum‐exposed sickle‐cell trait children
Objectives: The sickle‐cell trait phenotype is associated with protection from malaria. Multiple molecular mechanisms have been proposed to explain this protection, but the role of the host immune system has been poorly investigated. We hypothesised that cellular immunity to malaria may develop differently in sickle‐cell trait children (HbAS) and children with normal haemoglobin (HbAA) repeatedly exposed to Plasmodium falciparum (Pf).Methods: Paired samples collected prior to the Pf transmission season and during the first malaria episode of the ensuing transmission season from HbAS and HbAA children were analysed by multiplex bead‐based assay and comprehensive multi‐dimensional flow cytometry profiling.Results: Cellular immune profiles were enriched in HbAS relative to HbAA children before the start of the Pf transmission season, with a distinct NK subset. These cells were identified as a novel subset of memory‐activated NK cells characterised by reduced expression of the ecto‐enzyme CD38 as well as co‐expression of high levels of HLA‐DR and CD45RO. The frequency of this NK subset before the transmission season was negatively correlated with parasite density quantified during the first malaria episode of the ensuing transmission season. Functional assessment revealed that these CD38dim CD45RO+ HLA‐DR+ NK cells represent a important source of IFN‐γ.Conclusion: Our data suggest that this novel memory‐activated NK cell subset may contribute to an accelerated and enhanced IFN‐γ‐mediated immune response and to control of parasite density in individuals with the sickle‐cell trait. This distinct cellular immune profile may contribute to predispose HbAS children to a relative protection from malaria.
- 1 January 2020
- Published by Wiley in Clinical & Translational Immunology
- Vol. 9 (4) , e1125
Open AccessA novel population of memory‐activated natural killer cells associated with low parasitaemia in Plasmodium falciparum‐exposed sickle‐cell trait children
Objectives: The sickle‐cell trait phenotype is associated with protection from malaria. Multiple molecular mechanisms have been proposed to explain this protection, but the role of the host immune system has been poorly investigated. We hypothesised that cellular immunity to malaria may develop differently in sickle‐cell trait children (HbAS) and children with normal haemoglobin (HbAA) repeatedly exposed to Plasmodium falciparum (Pf).Methods: Paired samples collected prior to the Pf transmission season and during the first malaria episode of the ensuing transmission season from HbAS and HbAA children were analysed by multiplex bead‐based assay and comprehensive multi‐dimensional flow cytometry profiling.Results: Cellular immune profiles were enriched in HbAS relative to HbAA children before the start of the Pf transmission season, with a distinct NK subset. These cells were identified as a novel subset of memory‐activated NK cells characterised by reduced expression of the ecto‐enzyme CD38 as well as co‐expression of high levels of HLA‐DR and CD45RO. The frequency of this NK subset before the transmission season was negatively correlated with parasite density quantified during the first malaria episode of the ensuing transmission season. Functional assessment revealed that these CD38dim CD45RO+ HLA‐DR+ NK cells represent a important source of IFN‐γ.Conclusion: Our data suggest that this novel memory‐activated NK cell subset may contribute to an accelerated and enhanced IFN‐γ‐mediated immune response and to control of parasite density in individuals with the sickle‐cell trait. This distinct cellular immune profile may contribute to predispose HbAS children to a relative protection from malaria.
- 14 October 2019
- Published by Wiley in Immunological Reviews
- Vol. 293 (1) , 115-143
Deciphering host immunity to malaria using systems immunology
A century of conceptual and technological advances in infectious disease research has changed the face of medicine. However, there remains a lack of effective interventions and a poor understanding of host immunity to the most significant and complex pathogens, including malaria. The development of successful interventions against such intractable diseases requires a comprehensive understanding of host‐pathogen immune responses. A major advance of the past decade has been a paradigm switch in thinking from the contemporary reductionist (gene‐by‐gene or protein‐by‐protein) view to a more holistic (whole organism) view. Also, a recognition that host‐pathogen immunity is composed of complex, dynamic interactions of cellular and molecular components and networks that cannot be represented by any individual component in isolation. Systems immunology integrates the field of immunology with omics technologies and computational sciences to comprehensively interrogate the immune response at a systems level. Herein, we describe the system immunology toolkit and report recent studies deploying systems‐level approaches in the context of natural exposure to malaria or controlled human malaria infection. We contribute our perspective on the potential of systems immunity for the rational design and development of effective interventions to improve global public health.
- 14 October 2019
- Published by Wiley in Immunological Reviews
- Vol. 293 (1) , 115-143
Deciphering host immunity to malaria using systems immunology
A century of conceptual and technological advances in infectious disease research has changed the face of medicine. However, there remains a lack of effective interventions and a poor understanding of host immunity to the most significant and complex pathogens, including malaria. The development of successful interventions against such intractable diseases requires a comprehensive understanding of host‐pathogen immune responses. A major advance of the past decade has been a paradigm switch in thinking from the contemporary reductionist (gene‐by‐gene or protein‐by‐protein) view to a more holistic (whole organism) view. Also, a recognition that host‐pathogen immunity is composed of complex, dynamic interactions of cellular and molecular components and networks that cannot be represented by any individual component in isolation. Systems immunology integrates the field of immunology with omics technologies and computational sciences to comprehensively interrogate the immune response at a systems level. Herein, we describe the system immunology toolkit and report recent studies deploying systems‐level approaches in the context of natural exposure to malaria or controlled human malaria infection. We contribute our perspective on the potential of systems immunity for the rational design and development of effective interventions to improve global public health.
- 18 March 2019
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 220 (5) , 830-840
Increased CXCR3+ T Cells Impairs Recruitment of T-Helper Type 17 Cells via Interferon γ and Interleukin 18 in the Small Intestine Mucosa During Treated HIV-1 Infection
The restoration of CD4+ T cells, especially T-helper type 17 (Th17) cells, remains incomplete in the gut mucosa of most human immunodeficiency virus type 1 (HIV-1)–infected individuals despite sustained antiretroviral therapy (ART). Herein, we report an increase in the absolute number of CXCR3+ T cells in the duodenal mucosa during ART. The frequencies of Th1 and CXCR3+ CD8+ T cells were increased and negatively correlated with CCL20 and CCL25 expression in the mucosa. In ex vivo analyses, we showed that interferon γ, the main cytokine produced by Th1 and effector CD8+ T cells, downregulates the expression of CCL20 and CCL25 by small intestine enterocytes, while it increases the expression of CXCL9/10/11, the ligands of CXCR3. Interleukin 18, a pro-Th1 cytokine produced by enterocytes, also contributes to the downregulation of CCL20 expression and increases interferon γ production by Th1 cells. This could perpetuate an amplification loop for CXCR3-driven Th1 and effector CD8+ T cells recruitment to the gut, while impairing Th17 cells homing through the CCR6-CCL20 axis in treated HIV-1–infected individuals.
- 18 March 2019
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 220 (5) , 830-840
Increased CXCR3+ T Cells Impairs Recruitment of T-Helper Type 17 Cells via Interferon γ and Interleukin 18 in the Small Intestine Mucosa During Treated HIV-1 Infection
The restoration of CD4+ T cells, especially T-helper type 17 (Th17) cells, remains incomplete in the gut mucosa of most human immunodeficiency virus type 1 (HIV-1)–infected individuals despite sustained antiretroviral therapy (ART). Herein, we report an increase in the absolute number of CXCR3+ T cells in the duodenal mucosa during ART. The frequencies of Th1 and CXCR3+ CD8+ T cells were increased and negatively correlated with CCL20 and CCL25 expression in the mucosa. In ex vivo analyses, we showed that interferon γ, the main cytokine produced by Th1 and effector CD8+ T cells, downregulates the expression of CCL20 and CCL25 by small intestine enterocytes, while it increases the expression of CXCL9/10/11, the ligands of CXCR3. Interleukin 18, a pro-Th1 cytokine produced by enterocytes, also contributes to the downregulation of CCL20 expression and increases interferon γ production by Th1 cells. This could perpetuate an amplification loop for CXCR3-driven Th1 and effector CD8+ T cells recruitment to the gut, while impairing Th17 cells homing through the CCR6-CCL20 axis in treated HIV-1–infected individuals.
- 27 February 2019
- Published by Taylor & Francis in Expert Review of Vaccines
- Vol. 18 (3) , 241-251
Human challenge models: tools to accelerate the development of malaria vaccines
Malaria challenge models, where healthy human volunteers are intentionally infected with Plasmodium species parasites under controlled conditions, can be undertaken in several well-defined ways. These challenge models enable evaluation of the kinetics of parasite growth and clearance, host-pathogen interactions and the host immune response. They can facilitate discovery of candidate diagnostic biomarkers and novel vaccine targets. As translational tools they can facilitate testing of candidate vaccines and drugs and evaluation of diagnostic tests. Until recently, malaria human challenge models have been limited to only a few Plasmodium falciparum strains and used exclusively in malaria-naïve volunteers in non-endemic regions. Several recent advances include the use of alternate P. falciparum strains and other species of Plasmodia, as well as strains attenuated by chemical, radiation or genetic modification, and the conduct of studies in pre-exposed individuals. Herein, we discuss how this diversification is enabling more thorough vaccine efficacy testing and informing rational vaccine development. The ability to comprehensively evaluate vaccine efficacy in controlled settings will continue to accelerate the translation of candidate malaria vaccines to the clinic, and inform the development and optimisation of potential vaccines that would be effective against multiple strains in geographically and demographically diverse settings.
- 27 February 2019
- Published by Taylor & Francis in Expert Review of Vaccines
- Vol. 18 (3) , 241-251
Human challenge models: tools to accelerate the development of malaria vaccines
Malaria challenge models, where healthy human volunteers are intentionally infected with Plasmodium species parasites under controlled conditions, can be undertaken in several well-defined ways. These challenge models enable evaluation of the kinetics of parasite growth and clearance, host-pathogen interactions and the host immune response. They can facilitate discovery of candidate diagnostic biomarkers and novel vaccine targets. As translational tools they can facilitate testing of candidate vaccines and drugs and evaluation of diagnostic tests. Until recently, malaria human challenge models have been limited to only a few Plasmodium falciparum strains and used exclusively in malaria-naïve volunteers in non-endemic regions. Several recent advances include the use of alternate P. falciparum strains and other species of Plasmodia, as well as strains attenuated by chemical, radiation or genetic modification, and the conduct of studies in pre-exposed individuals. Herein, we discuss how this diversification is enabling more thorough vaccine efficacy testing and informing rational vaccine development. The ability to comprehensively evaluate vaccine efficacy in controlled settings will continue to accelerate the translation of candidate malaria vaccines to the clinic, and inform the development and optimisation of potential vaccines that would be effective against multiple strains in geographically and demographically diverse settings.
- Open Access
- 1 September 2016
- Published by Elsevier in Mucosal Immunology
- Vol. 9 (5) , 1137-1150
CCR6− regulatory T cells blunt the restoration of gut Th17 cells along the CCR6–CCL20 axis in treated HIV-1-infected individuals
- 1 September 2016
- Published by Elsevier in Mucosal Immunology
- Vol. 9 (5) , 1137-1150
Open AccessCCR6− regulatory T cells blunt the restoration of gut Th17 cells along the CCR6–CCL20 axis in treated HIV-1-infected individuals